Rising and Higher Healthcare Resource Utilization (HCRU) and Costs of Nonalcoholic Fatty Liver Disease (NAFLD)/Nonalcoholic Steatohepatitis (NASH) Patients with Advanced Liver Disease of Increasing Severity - Results of a US Real-World Analysis

被引：0
|
作者：
Wong, Robert J. [1 ]
Kachru, Nandita [2 ]
Meyer, Nicole [3 ]
Gordon, Stuart C. [4 ]
机构：
[1] Highland Hosp, Alameda Hlth Syst, Div Gastroenterol & Hepatol, Oakland, CA USA
[2] Gilead Sci, Foster City, CA USA
[3] Truven Hlth Analyt, Cambridge, MA USA
[4] Henry Ford Hlth Syst, Detroit, MI USA
来源：
HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2268
引用
收藏
页码：1283A / 1284A
页数：2
相关论文
共 50 条
  • [11] Molecular Mechanisms of Nonalcoholic Fatty Liver Disease (NAFLD)/Nonalcoholic Steatohepatitis (NASH)
    Ota, Tsuguhito
    CAROTENOIDS: BIOSYNTHETIC AND BIOFUNCTIONAL APPROACHES, 2021, 1261 : 223 - 229
  • [12] Real-World Health-Care Costs Impacted by Diabetes Mellitus (DM) among Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis (NAFLD/NASH) Patients with Advanced Liver Diseases (AdvLD)
    Wong, Robert
    Kachru, Nandita
    Martinez, Diane
    Moynihan, Meghan
    Ozbay, A. Burak
    Gordon, Stuart
    DIABETES, 2019, 68
  • [13] Comorbidities and healthcare costs and resource use of patients with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) in the Japan medical data vision database
    Terai, Shuji
    Buchanan-Hughes, Amy
    Ng, Alvin
    Lee, I-Heng
    Hasegawa, Ken
    JOURNAL OF GASTROENTEROLOGY, 2021, 56 (03) : 274 - 284
  • [14] Comorbidities and healthcare costs and resource use of patients with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) in the Japan medical data vision database
    Shuji Terai
    Amy Buchanan-Hughes
    Alvin Ng
    I-Heng Lee
    Ken Hasegawa
    Journal of Gastroenterology, 2021, 56 : 274 - 284
  • [15] Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
    Drescher, Hannah K.
    Weiskirchen, Sabine
    Weiskirchen, Ralf
    CELLS, 2019, 8 (08)
  • [16] Increased Risk of Mortality in Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis (NAFLD/NASH) Patients: Real-World Analysis of 2007-2015 Medicare Data
    Loomba, Rohit
    Fraysse, Jeremy
    Li, Suying
    Harrison, Stephen A.
    HEPATOLOGY, 2018, 68 : 1294A - 1294A
  • [17] HEALTHCARE RESOURCE UTILIZATION, DEMOGRAPHICS, AND COMORBIDITIES BY DIAGNOSIS CODES AND HISTOLOGICAL STAGE IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)/NONALCOHOLIC STEATOHEPATITIS (NASH) IN A LARGE INTEGRATED HEALTHCARE DELIVERY SYSTEM IN THE US
    Nyberg, Lisa M.
    Patton, Heather
    Chiang, Kevin M.
    Yang, Su-Jau
    Caparosa, Susan
    Stern, Julie
    Nyberg, Anders H.
    GASTROENTEROLOGY, 2019, 156 (06) : S1283 - S1283
  • [18] Rising Healthcare Costs and Comorbidities Among Nonalcoholic Steatohepatitis (NASH) Patients with Advanced Fibrosis and Cirrhosis: A Longitudinal Real-World Analysis of US Patients
    Loomba, Rohit
    Hulbert, Erin
    Shreay, Sanatan
    Harrison, Stephen A.
    HEPATOLOGY, 2017, 66 : 1131A - 1132A
  • [19] Vitamin D deficiency and development of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH)
    Bril, Fernando
    Lomonaco, Romina
    Orsak, Beverly
    Ortiz-Lopez, Carolina
    Biernacki, Diane
    Klaczak, Ashley
    Chang, Zhi
    Hardies, Jean
    Cusi, Kenneth
    HEPATOLOGY, 2013, 58 : 522A - 522A
  • [20] Variants of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) with rapidly progressive course
    Tan, V.
    Merriman, R.
    Ferrell, L.
    LABORATORY INVESTIGATION, 2008, 88 : 317A - 317A
12345